The page cannot be found

The page you are looking for might have been removed, had its name changed, or is temporarily unavailable.

Please try the following:

  • Make sure that the Web site address displayed in the address bar of your browser is spelled and formatted correctly.
  • If you reached this page by clicking a link, contact the Web site administrator to alert them that the link is incorrectly formatted.
  • Click the Back button to try another link.

HTTP Error 404 - File or directory not found.
Internet Information Services (IIS)

Technical Information (for support personnel)

  • Go to Microsoft Product Support Services and perform a title search for the words HTTP and 404.
  • Open IIS Help, which is accessible in IIS Manager (inetmgr), and search for topics titled Web Site Setup, Common Administrative Tasks, and About Custom Error Messages.
AIDS Responsibility Project
Wednesday, September 8, 2010 









ARP ED Abner Mason to join AEI Panel on Obstacles to Treatment in Africa
April 29, 2004
 
Please register online at http://www.aei.org/events.

The Obstacles to Treating AIDS, Malaria, and Tuberculosis in Developing Countries

Wednesday, May 12, 2004, 9:00 a.m.-noon Wohlstetter Conference Center, Twelfth Floor, AEI 1150 Seventeenth Street, N.W., Washington, D.C. 20036

Millions in Africa and the rest of the developing world suffer from HIV/AIDS, malaria, and tuberculosis. What is the best way to treat them? Since President George W. Bush's pledge of $15 billion to fight these diseases, controversy has developed over strategies and methods. Last month at a conference in Botswana, delegates wrestled with the issue of fixed-dose combinations of anti-retroviral drugs, which have not been approved by the Food and Drug Administration but were "pre-qualified" by the World Health Organization. Are such drugs safe? Or does their use risk the development of new resistant strains of HIV? Activists have accused drug companies, with the support of the Bush administration, of trying to block the use of cheaper generics, but new research indicates that only a small fraction of drugs in the developing world is patented. This conference will focus on ways that policymakers should confront the true obstacles to treating pandemic diseases in the developing world.

8:45 a.m. Registration

9:00 Introduction: JAMES K. GLASSMAN, AEI

9:15 Panel I: What's the Problem? Patents, Prices, Innovation, or Infrastructure?

Panelists:
AMIR ATTARAN, Royal Institute of International Affairs (London)
NICHOLAS EBERSTADT, AEI
DONALD ROBERTS, Uniform Services University of the Health Sciences
RICHARD TREN, Africa Fighting Malaria (Johannesburg)

Moderator:
ROGER BATE, AEI

10:45
Panel II: Which Drugs Should the United States Support?

Panelists:
CAROL ADELMAN, Hudson Institute
SCOTT GOTTLIEB, Food and Drug Administration
ABNER MASON, Presidential Advisory Council on HIV/AIDS

Moderator:
JAMES K. GLASSMAN, AEI

Noon
Adjournment

Please register online at http://www.aei.org/events.

Shortly after the event occurs, a video webcast will be available on the AEI website at http://www.aei.org/events/eventvideo_list.asp.

For additional information, please contact Sharon Utz at health@aei.org. For media inquiries, please contact Veronique Rodman at vrodman@aei.org.


View photos from several AIDS Responsibility Project events from across the globe here..
As a result of our successful trip to Latin America, ARP has established a Stigma Reduction Program in Mexico and Brazil.
The AIDS Responsibility Project recently traveled to Africa to view first-hand the impact of the disease on the continent, and the challenges facing those who provide services to these people.
Enter your email address for updates on the latest news from ARP.
© 2003-2005 AIDS Responsibility Project. All Rights Reserved.
Site by Level671, LLC.